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Cooperation between Syk and Rac1
Leads to Synergistic JNK Activation
in T Lymphocytes
subunits (Weiss and Littman, 1994). This results in re-
cruitment of Src homology-2 (SH2)±containing proteins
to the TCR complex. In some T cell subsets Syk kinases
are constitutively associated with the TCR complex and,
upon activation, recruit and activate other signaling mol-
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ecules, including Src kinases (Thome et al., 1995). Al-9500 Gilman Drive
though the exact order of events and the immediateLa Jolla, California 92093-0636
downstream targets of these PTKs are not fully estab-
lished, their importance in T cell signaling and develop-
ment are well recognized. Mutations in genes encoding
Summary these PTKs impair lymphocyte signaling, development,
and immune regulation (Arpaia et al., 1994; Lowell and
The MAP kinase (MAPK) JNK but not ERK is synergis- Soriano, 1996; Groves et al., 1996; van Oers et al., 1996).
tically activated during costimulation of T cells. We Events involved in the transmission of signals from
examined how protein tyrosine kinases (PTKs) and CD28 or other auxiliary receptors remain nebulous. It
GTPases differentially regulate JNK and ERK in T cells. also is not clear how PTK activation eventually leads to
While PTKs are not selective, small GTPases display IL-2 gene induction. However, as in other cell types in
distinct MAPK-activating functions. Whereas Ras acti- which receptor PTKs transduce extracellular signals to
vates ERK, Rac activates JNK. Rac cooperates with stimulate gene transcription (Marshall, 1995), a similar
a Syk-generated signal to enhance JNK activation and scheme probably applies to cytoplasmic PTKs in T cells
appears to be at a nodal point for pathways emanating (Weiss and Littman, 1994). Stimulation of receptor PTKs
from CD28, calcineurin, and protein kinase C. AP-1± results in activation of mitogen-activated protein kinase
and NF-AT±dependent reportersare stimulated by Rac (MAPK) cascades via small guanosine triphosphate
and Syk and are dependent on JNK. Unlike Syk, the (GTP)±binding proteins (Karin and Hunter, 1995; Marais
and Marshall, 1996). MAPKs play a critical role in trans-PTK Lck activates JNK but does not cooperate with
mitting signals generated by PTKs to the nucleus (KarinRac, resulting in weak AP-1 and NF-AT activation.
and Hunter, 1995; Su and Karin, 1996). Once activatedTherefore, signals generated by PTKs are functionally
in the cytoplasm, MAPKs translocate to the nucleusdistinct and need to be integrated to induce transcrip-
to phosphorylate and thereby stimulate specific trans-tional responses.
cription factors. In addition to the extracellular signal±
regulated kinases (ERKs), the MAPK family includes theIntroduction
c-Jun N-terminal kinases (JNKs) and p38s, also known
as stress-activated protein kinases (Su and Karin, 1996).
T cells requirecostimulation for full activation (Schwartz,
Different MAPKs have distinct yet overlapping substrate
1992). Although antigen presented by the major histo-
specificities. For example, only the JNKs phosphorylate
compatibility complex is recognized by the T cell recep- c-Jun, whereas both JNKs and p38s phosphorylate
tor (TCR), leading to activation of cytoplasmic protein ATF2 (Su and Karin, 1996) and only p38 phosphorylates
tyrosine kinases (PTK), these signals are not sufficient MEF2C (Han et al., 1997). All three groups of MAPKs
for full T cell activation (Schwartz, 1992). Additional sig- phosphorylate Elk-1 (Cavigelli et al., 1995; Price et al.,
nals provided by occupancy of auxiliary receptors, such 1996).
as CD28, by ligands on thesurface of antigen-presenting In T lymphocytes, JNK is synergistically activated by
cells are necessary (Linsley and Ledbetter, 1993). En- costimulation of the TCR/CD3 and CD28 receptors or
gagement of these receptors triggers pathways that are by combined treatment with phorbol myristate acetate
integrated to induce transcription of the gene for in- (PMA) and Ca21 ionophore (Su et al., 1994). In contrast
terleukin-2 (IL-2), a major T cell growth factor (Linsley to JNK, no synergy is observed in ERK activation. While
and Ledbetter, 1993). Absence of costimulation leads ineffective in JNK activation, either TCR engagement or
to an anergic state in which T cells lose the ability to PMA alone can fully activate ERK. The synergistic JNK
induce IL-2 upon restimulation (Schwartz, 1992). activation response is unique to T cells (Su et al., 1994)
Cytoplasmic PTKs, including members of the Src (Lck and B cells (Healy et al., 1997) and so far has not been
and Fyn) and Syk (ZAP70 and Syk) families, play a critical not observed in any other cell types. The response of
MAPKs to signals emanating from PTKs is dependentrole in transmission of signals from the TCR complex
on small GTPases such as Ras and Rac (Coso et al.,(Weiss and Littman, 1994; Wange and Samelson, 1996).
1995; Minden et al., 1995). Ras is necessary and suffi-Other PTKs, such as the Tec family (ITK/EMT), have
cient for ERK activation (Marais and Marshall, 1996).been suggested to transmit signals from CD28 (August
However, it is necessary but insufficient for JNK activa-et al., 1994). Upon activation, the Src PTKs Lck and Fyn
tion (Su and Karin, 1996). The latter is more dependentphosphorylate immunoreceptor tyrosine-based activa-
on activation of Rac or Cdc42, which are not involvedtion motifs (ITAM) in the cytoplasmic domains of TCR
in ERK activation (Coso et al., 1995; Minden et al., 1995).
These findings were made in fibroblasts and epithelial
cells, but the role of these proteins in T cell activation*To whom correspondence should be addressed (karinoffice@
ucsd.edu). has heretofore not been identified.
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The importance of JNK for IL-2 induction is also sug- TCR occupancy (anti-CD3) or PMA, JNK activity is stim-
ulated only weakly by these agonists. Potent JNK activa-gested by the role of the AP-1 transcription factor, com-
posed of Jun and Fos subunits. In addition to binding tion requires co-occupancy of CD3 and CD28 or coin-
cubation with PMA and Ca21 ionophore. Neither CD28AP-1 recognition sites, AP-1 assists the Ca21-respon-
sive, cyclosporin A (CsA)±sensitive nuclear factors of occupancy nor Ca21 ionophore activates JNK by itself
(Su et al., 1994). PTKs that couple receptor stimulationactivated T cells (NF-ATc) to bind stably the composite
NF-AT recognition element in the IL-2 promoter (Rao, to downstream targets may lead to activation of either
JNK or ERK or both. We therefore compared the abilities1994). NF-ATc activity is regulated mostly posttrans-
lationally; in nonstimulated cells, the NF-ATc proteins of Src (Lck and Fyn) and Syk (Syk and ZAP70), PTKs
that are predominantly expressed in T cells, to activatereside in the cytoplasm but in response to stimula-
tion by PMA and Ca21 ionophore, they translocate to JNK and ERK. Wild-type and activated forms of Lck and
Fyn (Cooke and Perlmutter, 1989; Wright et al., 1994)the nucleus. This nuclear translocation is Ca21 and cal-
cineurin dependent and sensitive to CsA (Rao, 1994). and wild-type Syk and ZAP70 (Chan et al., 1992; Couture
et al., 1994) were tagged with the hemagglutinin (HA)AP-1 activity is regulated both transcriptionally and
posttranscriptionally, but once synthesized, AP-1 sub- epitope, so their expression could be compared. Plas-
mids encoding each of these PTKs were cotrans-units are constitutively nuclear (Karin et al., 1997). In
nonstimulated T cells, the basal levels of AP-1 proteins fected with Flag (M2)±tagged JNK1 or HA-ERK2 expres-
sion vectors (Minden et al., 1994) into the Jurkat T cellare low but T cell activationresults in induction of jun and
fos genes and increased synthesis of AP-1 components line. We found that Lck and Syk activate JNK, but Fyn
and ZAP70 were considerably less potent (Figure 1A).(Rincon and Flavell, 1994; Su et al., 1994). This process
depends on activation of JNK and other MAPKs (Su et The observed activation of JNK by Lck or Syk, how-
ever, is incomplete when compared to the effect ofal., 1994). In addition to stimulating preexisting factors
involved in c-jun or c-fos induction, the JNKs phosphor- PMA1A23187. Similar effects on JNK activity were also
obtained using untagged PTK constructs (data notylate newly synthesized c-Jun or JunD proteins and
enhance their ability to activate transcription (Karin et shown). We also found that untagged Lck, Fyn, and Syk
activate ERK to about the same degree, which was onlyal., 1997). By phosphorylating Elk-1 (Price et al., 1996)
and MEF2C (Han et al., 1997), the p38 MAPKs also par- a bit lower than the response to PMA, the most effective
ERK activator in Jurkat cells (Figure 1B).ticipate in fos and jun gene induction and stimulation
of AP-1 activity. We further investigated the role of Lck and Syk in
MAPK activation. We compared the response of theA critical role for MAPKs in T cell activation is under-
scored by studies of anergic T cells that demonstrated Jurkat variant JCaM1.6, which is defective in Lck ex-
pression (Straus and Weiss, 1992), with that of a re-that both JNK and ERK activation are diminished follow-
ing TCR restimulation (Fields et al., 1996; Li et al., 1996). constituted derivative, JCaM1/lck, which expresses
functional Lck. JCaM1/lck responds normally to TCRThis observation accounts for a defective AP-1 response
(Kang et al., 1992) and impaired expression of some occupancy in terms of Ca21 spikes and induction of
tyrosine phosphorylation (Straus and Weiss, 1992). CD3AP-1 proteins in anergic T cells (Mondino et al., 1996).
Hence, a better understanding of the pathways that reg- and CD28 expression levels were comparable in both
cell lines as determined by fluorescence-activated cellulate MAPKs is relevant for elucidating the mechanisms
of T cell activation and anergy. sorter analysis (data not shown). Immunoblotting re-
vealed large differences in expression of the differentTo define the pathways accounting for differential reg-
ulation of MAPKs and to identify the signals that need modified forms of Lck between the two cell lines (Straus
and Weiss, 1992) (Figure 2A). Costimulation with anti-to be integrated for potent JNK activation, we analyzed
the role of cytoplasmic PTKs and small GTPases in these bodies to CD3 and CD28 resulted in synergistic JNK
activation in the Lck-expressing cells, while noJNK acti-processes. We show that Lck is required for both JNK
and ERK activation through the CD3 receptor. While Syk vation was observed in the Lck-defective cell line (Figure
2A). We noticed higher basal JNK activity in the Lck2may not be required for JNK activation, its presence
can enhance the JNK response to CD3 and CD28 co- cells, and thus the fold activation was lower in these
cells compared to that of the Lck1 cells. Lck, however,stimulation. Our results indicate that whereas Lck and
Syk activate both JNK and ERK in transfection assays, is not required for activation of JNK by PMA. When PMA
was combined with A23187 or anti-CD28 in the defectiveRac1 can cooperate with Syk but not Lck to cause a
further increase in JNK activity. In contrast, Rac1 does cell line, synergistic JNK activation was still observed
but not when anti-CD3 was used as a costimulus (Figurenot activate ERK and does not potentiate its activation
by either Lck or Syk. In addition, Rac1 can couple the 2A). However, CD28 ligation potentiated the response
CD3, CD28, and protein kinase C (PKC) signals to JNK to PMA by 7-fold in Lck1 cells and by only 3±4-fold in
activation. Consistent with the convergence of the Syk Lck2 cells. These results suggest that Lck is not required
and Rac pathways in JNK activation, the same signals for the transmission of signals generated by PMA or
also synergize to induce AP-1 and NF-AT transcriptional Ca21 ionophore leading to JNK activation and that it has
activities. only a minor role in the response to CD28 occupancy.
Since overexpression of Syk can activate JNK partially
Results (Figure 1A), we tested whether this signal can be en-
hanced by a second signal. Our results show that activa-
tion of JNK by Syk overexpression can be further in-Src and Syk PTKs Activate JNK and ERK
The MAPKs JNK and ERK are differentially regulated in creased upon activation with anti-CD3, anti-CD28, or
PMA, but not after treatment with Ca21 ionophore (FigureT cells. Whereas ERK is efficiently activated by either
Synergistic JNK Activation by Syk and Rac1
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Figure 2. Role of Lck and Syk in T Cell Costimulation
(A) The Jurkat variant JCaM1.6, which expresses a defective form
of Lck [Lck2], and a stably transfected form that expresses wild-
type Lck (JCaM/lck) [Lck1] each were stimulated for 30 min as
indicated. The activity of endogenous JNK immunoprecipitated with
anti-JNK (333.8) was determined using GST-c-Jun(1±79) as a sub-
strate and quantitated as in Figure 1. Expression of Lck was deter-Figure 1. Lck, Fyn, and Syk Are Involved in JNK and ERK Activation
mined by immunoblotting. Total protein concentration was mea-(A) To obtain equivalent expression of cytoplasmic PTKs, Jurkat
sured for each sample by Lowry assay (Bio-Rad). Fold activation ofTag cells were transfected with HA-tagged wild-type Lck (1 mg),
JNK was calculated after quantitating GST-c-Jun phosphorylationactivated Lck (HSB2-A1; 3 mg), wild-type Fyn (2 mg), activated Fyn
with a phosphoimager.(F528; 2 mg), wild-type Syk (1.5 mg), wild-type Zap70 (0.2 mg), or
(B) Jurkat Tag cells were transfected with either 2 mg of emptySRa empty vector (3 mg), together with 0.2 mg of M2-tagged JNK.
vector (SRa) or a Syk expression vector together with 0.2 mg of HA-Kinase activity was measured by immune complex kinase assay
JNK1 vector. Cells in 1 ml of suspension were subjected to theusing anti-M2 to immunoprecipitate JNK and GST-c-Jun(1±79) as
indicated stimuli and collected after 30 min. After determination ofa substrate. A sample of each lysate was analyzed for protein ex-
the level of HA-JNK1 in each sample by immunoblotting, JNKactivitypression by immunoblotting with anti-HA and anti-M2. Fold activa-
was determined by an immune complex kinase assay performed ontion was determined after quantitation with the phosphoimager (Bio-
equal amounts of HA-JNK1, as described in (A).Rad). vec, vector; wt, wild-type, act, activated; P/A, PMA1A23187.
(B) Jurkat Tag cells were transfected with untagged PTK expression
vectors (same concentrations as in [A]) together with 0.2 mg of HA- activation has been well studied in othercell types (Coso
ERKexpression vector. Protein expression andkinase activity, using et al., 1995; Minden et al., 1995). Ras has also been
anti-HA to immunoprecipitate HA-ERK and MBP as a substrate,
shown to couple TCR signals to ERK activation in T cellswere determined as described in (A).
(Cantrell, 1996), but the role of Rac in T cell activation
is not clear. We cotransfected the dominant inhibitory
Rac1(N17) mutant (Minden et al., 1995) with either Lck or2B). From these, most notable is the augmentation by
anti-CD28. As previously described (Su et al., 1994), Syk and an HA-JNK1 vector. We observed no significant
inhibitory effect of Rac1(N17) on JNK activation by LckCD28 ligation by itself has a marginal effect on JNK
activity. However, when combined with Syk overex- and Syk (Figure 3A). These results stand in marked con-
trast to the ability of Rac1(N17) to inhibit JNK activationpression, CD28 ligation activated JNK as efficiently as
CD31CD28 ligation in mock-transfected cells (Figure by Src in NIH3T3 or HeLa cells (Minden et al., 1995).
This led us to investigate whether in T cells Lck or2B). It should be noted, however, that none of the co-
stimulations in Syk transfected cells resulted in full Syk may act in parallel with Rac. We therefore tested
whether activated Rac1 can synergize with the Lck- orJNK activation when compared to the PMA1A23187
treatment. Syk-generated signals. As observed in other cell types
(Coso et al., 1995; Minden et al., 1995), Rac1(V12) acti-
vates JNK efficiently by itself in Jurkat cells (Figure 3B).Rac1 Cooperates with Syk but Not Lck
to Enhance JNK Activation While Lck or Syk have a modest effect on JNK activity,
coexpression of Rac1(V12) potentiates JNK activationSince no major difference in the pattern of MAPK activa-
tion was observed between Lck and Syk overexpres- by Syk but not by Lck. In fact, Rac1(V12) can actually
decrease JNK activation by Lck. We also tested whethersion, we searched for possiblemodulators of their effect.
The role of the small GTPases Ras and Rac in MAPK an activated form of Ras will synergize with Lck or Syk.
Immunity
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Figure 3. Rac1 Potentiates and Couples Costimulating Signals to JNK Activation
(A) Jurkat Tag cells were transfected with 2 mg of activated Lck or wild-type Syk expression vector together with 0.2 mg of HA-JNK1 and
either an empty expression vector or 1±5 mg of Rac1(N17). The total amount of DNA transfected was kept constant using empty SRa expression
vector. After determining and normalizing for HA-JNK1 expression, its kinase activity was measured as described for Figure 1. Expression of
Myc-tagged Rac1(N17) was also examined by an immunoblot (data not shown). The average fold activation of HA-JNK1 was determined by
three independent transfection experiments.
(B) Jurkat Tag cells were transfected alone or in combination with 2 mg each of expression vectors coding for activated Lck, wild-type Syk,
or Rac1(V12), together with 0.2 mg of HA-JNK1 vector. After normalizing HA-JNK1 expression determined by immunoblotting, its kinase activity
was measured by an immunecomplex kinase assay. Rac1(V12) expression was examined by immunoblotting.
(C) Jurkat cells were transfected as in (B) but with 0.2 mg of HA-ERK2 expression vector instead of HA-JNK. After normalizing for HA-ERK2
expression by immunoblotting, kinase activity was determined by immune complex kinase assay using MBP as a substrate.
(D) Jurkat Tag cells were transfected with increasing amounts of Rac1(N17) together with 0.2 mg of HA-JNK1. The cells were subjected to
the indicated stimuli, and after 30 min lysates were prepared. JNK activity and protein expression were measured. ns, not stimulated; 3/28,
anti-CD31anti-CD28; P/A, PMA1A23187.
(E) Jurkat cells were transfected with 5 mg of either Rac1(N17) or an empty SRa expression vector and subjected to the indicated stimuli for
30 min prior to determination of JNK activity and protein expression.
Synergistic JNK Activation by Syk and Rac1
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Ras(L61) alone did not activate JNK significantly, nor was not induced by expression of Syk, Lck, and Rac1
(Figure 4D).did it synergize with either Lck or Syk even at high
expression levels. Like Rac1(V12), expression of Ras(L61)
attenuated the response of JNK to Lck or Syk (data not Syk Can Induce NFAT Activity More Potently
Than Lck, and This Induction Is Onlyshown).
We tested the effect of Rac1(V12) on ERK activation Partially Sensitive to CsA
Induction of IL-2 is a key event in T cell activation. Tran-and found that Rac1(V12) by itself did not activate ERK,
nordid it potentiate ERK activation by Sykor Lck expres- scription of IL-2 is controlled by several cis-acting ele-
ments, one of which, the NF-AT recognition site, wassion despite efficient expression of the protein (Figure
3C). ERK activity, however, was stimulated by Ras(L61) shown to have a lymphoid-specific role (Rao, 1994). We
investigated how signals from Lck can lead to inductionexpression (data not shown).
We next examined whether Rac1 is involved in the of NF-AT activity by using a reporter construct driven
by a minimal IL-2 promoter (272 to 147), upstream ofcostimulatory signals generated by PMA and Ca21 iono-
phore or anti-CD3 and anti-CD28. Dominant negative which three NF-AT binding sites were inserted (Northrop
et al., 1993). Occupancy of this NF-AT site and promoterRac1(N17) was cotransfected with HA-JNK1 and the
cells were costimulated with anti-CD31anti-CD28 or activation require cooperative binding of NF-ATc pro-
teins and AP-1 transcription factors (Rao, 1994). SykPMA1Ca21 ionophore. We observed diminished JNK
activation in response to increasing amounts of Rac1(N17) expression strongly increased NF-AT-LUC expression,
which was further enhanced (2-fold) by Ca21 ionophore(Figure 3D). Rac1(N17) can inhibit the response to anti-
CD31anti-CD28 almost fully. Inhibition of the response but not by PMA (Figure 5A). In fact, consistent reduction
in NF-AT reporter activity was observed when Syk-to PMA1Ca21 ionophore was less complete. We further
examined the effect of Rac1(N17) on JNK activation by transfected cells were costimulated with PMA. Costimu-
lation with PMA and Ca21 ionophore strongly inducedcombining PMA and other agonists. We found that
Rac1(N17) can inhibit PMA-mediated JNK activation by NF-AT activity, as expected (Northrop et al., 1993), and
this effect was not augmented by coexpression of Syk3-fold (Figure 3E). When PMA was combined with anti-
CD3 or Ca21 ionophore, the same degree of inhibition (Figure 5A). While the response to PMA1Ca21 ionophore
was almost completely inhibited by CsA, the responsewas observed. However, when the cells were costimu-
lated with PMA1anti-CD28, as much as 7-fold inhibition to Syk was only partially inhibited (250-fold inhibition of
PMA1Ca21 ionophore stimulation vs. 3-fold inhibitionof JNK activation was obtained. These results suggest
that Rac1 is involved in JNK activation by PMA and is of the response to Syk) (Figure 5B).
When the activated Lck was cotransfected with theprobably also involved in the costimulatory CD28
pathway. NF-AT-LUC reporter, we observed only a 10-fold induc-
tion of reporter activity (Figure 5A). Ca21 ionophore
strongly synergized with Lck, leading to about 300-
Syk Increases AP-1 Activity fold induction of NF-AT-LUC expression. On the other
JNK phosphorylates the transactivation domain of tran- hand, no further induction was observed when Lck-
scription factor c-Jun, which dimerizes with other Jun transfected cells were costimulated with PMA. The in-
and Fos family members and induces transcription from duction of NF-AT-LUC by PMA1Ca21 ionophore was
promoters containing AP-1 recognition elements (Karin maximal and was not further enhanced by Lck expres-
et al., 1997). JNK activation also correlates with induc- sion. We next examined whether the increase in NF-
tion of c-jun transcription (Karin, 1995; Karin et al., 1997). AT activity by Lck expression is mediated by a Ca21-
We used a 279 c-jun-luciferase (LUC) reporter to assess dependent or -independent signal. About 50% inhibition
the induction of c-jun transcription and to correlate it of NF-AT-LUC induction by Lck was observed when the
with activation of JNK by Lck and Syk. Cotransfection of cells were pretreated with CsA (Figure 5B).These results
c-jun-LUC with Syk results in 6-fold inductionof reporter suggest that activation of the NF-AT reporter by Lck and
gene expression (Figure 4A). The response to Syk was Syk relies only partly on a Ca21-dependent component,
not significantly increased by either PMA or Ca21 iono- which most likely involves calcineurin.
phore (Figure 4A) and is only slightly sensitive to CsA Since Rac1 can potentiate JNK activation and induc-
(Figure 4B). The observed induction by Syk is not as tion of c-jun transcription by Syk, we examined its effect
high as the effect of PMA1Ca21 ionophore. Overexpres- on induction of NF-AT-LUC expression by Syk. When
sion of active Lck minimally induced c-jun-LUC tran- Rac1(V12) alone was transfected with the NF-AT-LUC
scription (2-fold) and was not potentiated by either PMA reporter, no induction of NF-AT activity was observed
or ionophore (data not shown); it also was not sensitive (Figure 5C). Rac1(V12) also did not potentiate the weak
to CsA (Figure 4B). response to Lck. Rac1(V12) weakly potentiated (,2-
We also tested the effect of Rac1(V12) on c-jun pro- fold) the strong response of NF-AT-LUC tocoexpression
moter activation and examined whether it correlates of Syk.
with the synergistic activation of JNK when coexpressed
with Syk. Rac1(V12) induced transcription of c-jun-LUC, A p38/JNK Inhibitor Partially Inhibits Syk-
and this response was potentiated by coexpression of and Lck-Induced NF-AT Transcriptional
Syk (Figure 4C). This synergistic induction as well as Activity but Completely Inhibits c-jun
the lack of cooperation of Rac with Lck correlates well Promoter Activation
with the effects of these molecules on JNK activity. A To define whether JNK is necessary for the increase in
NF-AT transcriptional activity induced by Lck and Syk,reporter, 260 Col-LUC, lacking an AP-1 binding site,
Immunity
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Figure 4. Syk Stimulates c-jun Promoter Ac-
tivity
(A) Jurkat cells were cotransfected with 5 mg
of either Syk or an empty expression vector
along with 5 mg of 279 c-jun-LUC reporter
plasmid. After 24 hr, cells were stimulated
for another 12±16 hr as indicated and then
harvested. Luciferase activity was measured
and the results were expressed as average
fold-induction relative to nonstimulated, vec-
tor-transfected cells (assigned an arbitrary
value of 1). The averages of three experi-
ments are shown using a logarithmic scale
with standard error bars. ns, not stimulated;
P, PMA; A, A23187; P/A, PMA1A23187.
(B) Jurkat cells were transfected with 5 mg of
wild-type Syk, activated Lck, or empty vector
together with 5 mg of 279c-jun-LUC reporter.
CsA (50 ng/ml) was added 24 hr after trans-
fection. PMA and Ca21 ionophore (P/A) were
added as indicated 10 minutes after addition
of CsA. Cells were harvested after incubation
for another 12 hr and luciferase activity deter-
mined and expressed as in (A). Results shown
are averages of three independent experi-
ments.
(C) Jurkat cells were transfected with 5 mg
279 c-jun-LUC reporter and 5 mg of either
Lck or Syk expression vector with or without
5 mg of a Rac1(V12) vector. Luciferase activity
was measured as described in (A), and the
results reflect averages of three separate ex-
periments.
(D) Jurkat cells were transfected with 5 mg of
260 Col-LUC reporter and 5 mg of either Lck
or Syk expression vector, with or without 5
mg of Rac1(V12) vector. Luciferase activity
was measured as described in (A), and the
results are averages of three separate experi-
ments.
we used the compound SB202190, which was originally Discussion
described as a specific p38 inhibitor (Lee et al., 1994).
However, our laboratory has found that at levels that MAPKs play an important role in the transduction of
signals originating from cell surface receptors to theare 10-fold higher than those required for p38 inhibition,
SB202190 is an effective JNK inhibitor (C.-Y. Chen and transcriptional machinery in the nucleus (Karin and
Hunter, 1995; Marshall, 1995). In Jurkat T cells, occu-H. Le-Niculescu, unpublished data). Similar results were
obtained with another p38 inhibitor SB203580 (Whit- pancy of TCR/CD3 or incubation with PMA results in
efficient ERK activation but has only a marginal effectmarsh et al., 1997). Even when used at these higher
concentrations, these drugs do not inhibit ERK activity. on JNK activity. The latter requires costimulation pro-
vided by co-occupancy of CD3 and CD28 or simultane-Incubation with 40 mM SB202190 diminished Lck- and
Syk-induced NF-AT transcriptional activity by 50%, ous incubation with PMA1Ca21 ionophore (Su et al.,
1994). Such costimulation is also required for inductionwhile induction by PMA1Ca21 ionophore was almost
completely inhibited by the drug (Figure 6A). Induction of IL-2 transcription (Linsley and Ledbetter, 1993). The
correlation between costimulatory JNK activation andof NF-AT-LUC by cotransfection of activated PKC and
calcineurin expression vectors was also inhibited by 40 IL-2 induction suggests that activation of this group of
MAPKs and possibly the related p38 MAPKs, whosemM SB202190 (data not shown). At 4 mM, which is suffi-
cient for p38 but not JNK inhibition, SB202190 caused a regulation in T cells is very similar to that of the JNKs
(E. J., unpublished data), is a critical component of theconsiderably weaker inhibition of NF-AT-LUC induction.
The effect of this inhibitor on NF-AT transcriptional ac- pathway leading to IL-2 induction. The significance of
MAPKs in T cell activation is underscored by their dimin-tivity is likely to be due to inhibition of AP-1 activity,
because SB202190 completely inhibited induction of ished activation in anergic T cells, which correlates with
inhibition of IL-2 synthesis (DeSilva et al., 1996; Li et al.,c-jun-LUC also at 40 mM (Figure 6B). As shown in Figure
6C, treatment of Jurkat cells with 40 mM SB202190 re- 1996).
We investigated which signals are responsible for thesulted in complete inhibition of c-Jun phosphorylation.
Treatment with 4 mM SB202190 had only a marginal differential regulation of JNK and ERK activities by fo-
cusing on events that occur downstream of PTKs thateffect on c-Jun phosphorylation.
Synergistic JNK Activation by Syk and Rac1
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Figure 5. Lck and Syk Induce NF-AT Re-
porter Expression
(A) Jurkat cells were transfected with 2 mg of
either Lck, Syk, or empty expression vector
and 1 mg of an NF-AT-LUC reporter. Stimula-
tions and determination of luciferase activity
were performed as described for Figure 4.
Average results from at least three inde-
pendentexperiments are shown using a loga-
rithmic scale with standard error bars. ns,
not stimulated; P, PMA; A, A23187; P/A,
PMA1A23187.
(B) Transfections were performed as de-
scribed above. After 24 hr, the cells were
pretreated with CsA (50 ng/ml) for 10 min
and then stimulated where indicated with
PMA1A23187 (P/A) for 12±16 hr before har-
vesting. Luciferase activity was calculated
and expressed as described in (A).
(C) Jurkat cells were transfected with NF-AT-
LUC (1 mg) and 2 mg of either empty expres-
sion vector, Lck, Syk, or Rac1(V12) vectors.
Luciferase activity was measured and ex-
pressed as described in (A).
participate in TCR signaling. Our studies demonstrate with Lck. The same results are obtained either when JNK
activity is measured directly or through measurementthat PTKs of the Src and Syk families can stimulate both
JNK and ERK but that cooperation with other signaling of c-jun promoter activation, which depends on JNK
activation (Karin, 1995). The lack of enhancement of ERKcomponents, such as thesmall GTP binding protein Rac,
results in enhanced JNK activation without an effect on activity by Rac is consistent with the insensitivity of this
MAPK to costimulation.ERK activity. The costimulatory effect of Rac is much
more pronounced when combined with Syk rather than TCR stimulation results in recruitment and activation
Figure 6. JNK Is Involved in the Syk and Lck
Induction of NF-AT-LUC
(A) Jurkat cells were transfected with 2 mg of
empty vector, Lck, or Syk expression vector
together with 1 mg of NF-AT-LUC reporter.
After 24 hr, cells were treated with vehicle
alone or with either 4 or 40 mM of SB202190
added 15 min prior to PMA1Ca21 ionophore
(P/A) stimulation. Cells were harvested after
12 hr of incubation and assayed for luciferase
activity. The averages of three experiments
are displayed on a logarithmic scale with
standard error bars.
(B) Jurkat cells were transfected with 5 mg of
empty vector, Lck, or Syk expression vectors
together with 5 mg of 279 c-jun-LUC reporter.
The cells were treated with SB202190 and
assayed for luciferaseactivity. Results are av-
erages of three experiments.
(C) Jurkat cells were treated with 0.4 or 40
mM of SB202190. PMA1 Ca21 ionophore
(P/A) was added as indicated, 15 min later.
Cells were harvested after 12 hr of incubation.
N-terminal phosphorylation of c-Jun was ex-
amined by immunoblotting using anti-phos-
phoSer-73-c-Jun antibody. Total c-Jun ex-
pression was determined by probing the
same blot with anti-c-Jun.
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of PTKs. Phosphorylation of the ITAMs in the TCR is can also be potentiated by CD3, CD28, or PMA stim-
ulation (Figure 2B), it is possible that all of these stimuliattributed to Src kinases, such as Lck and Fyn, which
then trigger downstream signaling events including acti- act through Rac. Indeed, Rac1(N17) inhibited JNK
activation by anti-CD31anti-CD28, PMA1Ca21 iono-vation of MAPK cascades (Cantrell, 1996). The require-
ment for Lck in JNK activation through TCR/CD3 is phore, or PMA1anti-CD28 (Figures 3D and 3E). Whether
Lck, Fyn, or ZAP70 cooperate with other signals thatclearly shown by the lack of response in the Lck-defec-
tive cell line (JCaM1.6). While Lck is necessary, it is not lead to enhanced JNK activation remains to be exam-
ined. Of note, JNK activation by Rac1 is slightly attenu-sufficient for full JNK activation, as observed in Lck-
overexpressing cells (Figure1A). Other studieshave also ated by coexpression of Lck, suggesting the involve-
ment of a Lck-dependent negative signal that impingessuggested a requirement for Lck in CD28 signaling
(Raab et al., 1995), but our results indicate that at least on the Rac pathway. Consistent with this, we observed
decreased JNK activation by either anti-CD31anti-for JNK activation, Lck plays only a minor role in trans-
mitting CD28-generated signals (Figure 2A). CD28 or PMA1Ca21 ionophore in Lck-transfected cells
(data not shown).Syk overexpression, on theother hand, enhances JNK
activation by CD3, CD28, or PMA stimulation. Since all We examined the effects of the different signaling
proteins on AP-1± and NF-AT±dependent reporter geneJurkat (JE6)±derived clones, including the Lck-defective
JCaM1.6, were found to express a truncated form of expression. Although by itself Syk is a weak JNK activa-
tor, it is an efficient activator of the AP-1± and NF-AT±Syk (Fargnoli et al., 1995), the wild-type form of Syk is
not absolutely required for JNK activation in response dependent reporters. The other PTKsÐFyn, Lck, and
ZAP70Ðhad only a weak effect on reporter gene expres-to TCR engagement in these cells. Although Syk and
ZAP70 are differentially activated (Bu et al., 1995) and sion (Figures 4 and 5 and data not shown). Our results
point to the involvement of calcineurin in the Syk- asmay have distinct roles (Kolanus et al., 1993; Chu et al.,
1996), ZAP70, which is expressed normally in these cells well as Lck-triggered pathways. Indeed, CsA partially
blocked the Syk-induced activation of the NF-AT± and(Chan et al., 1992), may compensate for the absence of
functional Syk. Normal T cell signaling is also observed AP-1±dependent reporters. The CsA:cyclophilin com-
plex targets and inhibits the activity of calcineurin, ain mature T cells which express low levels of Syk and
in Syk-deficient mice (Turner et al., 1995). However, in Ca21-dependent phosphatase (Schreiber, 1992). Inhibi-
tion of calcineurin activityprevents nuclear translocationmice that are deficient in both ZAP70 and Syk, double-
negative thymocytes fail to expand and differentiate into of NF-ATc (Rao, 1994) and decreases Ca21 dependent
JNK activation and AP-1 transcriptional activity (Su etdouble-positive thymocytes (Cheng et al., 1997). Since
this phenotype is not observed in mice deficient in only al., 1994; Werlen et al., submitted). Other studies have
shown that clustering of a Syk chimera is sufficient toZAP70 or Syk, these PTKs must have overlapping func-
tions. Although transfection of wild-type ZAP70, unlike mobilize intracellular Ca21 in both T and B cells (Kolanus
et al., 1993; Takata et al., 1994). In JCaM cells thatSyk, led to only weak JNK activation (Figure 1A), these
results are consistent with the much lower level of ZAP70 are defective in Ca21 mobilization and express non-
functional forms of Lck and Syk, reconstitution of eitherbasal kinase activity (Latour et al., 1996) and the pres-
ence of endogenous ZAP70 in these cells. Lck or Syk expression can rescue Ca21 signaling (Straus
and Weiss, 1992; Chu et al., 1996), consistent with theirWe examined whether GTPases that mediate PTK sig-
nals diverge in their regulatory function by differentially overlapping functions in T cell development (Cheng et
al., 1997). In addition to their role in Ca21 signaling, Lckactivating MAPKs in T cells. We found that although Ras
activates ERK, it does not activate JNK even in the and Syk activate another component that leads toMAPK
activation. This can be deduced from the partial inhibi-presence of other stimuli (data not shown). We also
tested whether Ras can cooperate with Lck or Syk and tion of JNK activation by CsA and from the findings
that JNK is not activated solely by calcineurin (or Ca21found that it does not lead to enhanced activation of
either JNK or ERK. This is in contrast to the strong effect ionophore) and that calcineurin does not synergize with
Rac to enhanceJNK activation (Werlen et al., submitted).of Ras on NF-AT transcriptional activity in the presence
of Ca21 ionophore (Genot et al., 1996; E. J., unpublished In addition, both Syk and Lck can activateERK, indepen-
dently of a Ca21-triggerred signal (Williams et al., 1997)data). Different results were obtained by Faris et al.
(1996), who found that inducible Ras(V12) in stably (Figure 1B). Most likely, this secondcomponent involved
in both JNK and ERK activation by Syk or Lck is PKC.transfected Jurkat cells led to modest JNK activation.
Currently, the basis for this discrepancy is not clear. Proteins such as PLC-g, which is activated by PTKs
(Weiss and Littman, 1994; Law et al., 1996) may mediateInstead, as demonstrated in other cell types, Rac is more
closely linked to JNK activation than Ras (Coso et al., both their effects on PKC and Ca21 mobilization.
The strong effect of Syk on NF-AT±dependent tran-1995; Minden et al., 1995). In other cell types, Rac is
regulated by signals from PTK receptors or the v-Src scription is consistent with generation of both PKC- and
Ca21-dependent signals, which induce NF-AT transcrip-PTK (Coso et al., 1995; Minden et al., 1995). However,
we did not observe a dramatic inhibition by dominant tional activity. However, if Rac is transmitting these sig-
nals, it is paradoxical that Rac1(V12) does not inducenegative Rac1(N17) of Lck- and Syk-mediated JNK acti-
vation. It remains to be determined whether Rac medi- NF-AT±dependent transcription by itself. This could be
explained by our finding that Rac is specifically involvedates the response to another PTK in these cells. Our
results suggest that in Jurkat cells, Rac can function in in JNK activation, such that a Ras-dependent signal
(possibly mediated by ERK), which is crucial for NF-ATparallel to Syk, because it cooperates with it in JNK
activation (Figure 3B). Since Syk-induced JNK activation transcriptional activity (Cantrell, 1996), is not generated.
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by the nonsteroidal antiinflammatory drug SB202190 at
a concentration that fully inhibits JNK activity. Since this
drug has not been found to affect ERK activity, the Ras-
mediated signal may account for the incomplete inhibi-
tion of the NF-AT-LUC activity. Indeed, SB202190 had
a more potent effect on c-jun transcription, which is
responsive to both JNK (Karin, 1995) and p38 (Han et
al., 1997) activation.
Our results demonstrate that while both Lck and Syk
can activate JNK and ERK, these pathways bifurcate,
such that the Syk-generated signal converges with an-
other signal that is Rac dependent, leading to enhanced
JNK activation. In anergic T cells, a common regulatory
signal that leads to both JNK and ERK activation in
response to TCR/CD3 occupancy and that acts up-
stream of Ras is believed to be defective (Fields et al.,
1996; Li et al., 1996). Our findings indicate that the regu-
lation of JNK activity in T cells is dependent on Rac
rather than Ras. Thus, a common regulator or activator
of both small GTPases may be functionally impaired in
anergic cells. A decrease in tyrosine phosphorylation
has been demonstrated in restimulated anergic cells
(Quill et al., 1992). In contrast, other TCR/CD3-induced
events, such as NF-ATc dephoshorylation (Mondino et
al., 1996), were generally unaffected in these cells, sug-
gesting that a selective block in the MAPK±to±AP-1
pathway accounts for decreased IL-2 synthesis. Indeed,Figure 7. Signaling Pathways Leading to Stimulation of AP-1 and
NF-AT Activities in T Cells anergic cells display defective AP-1 activation (Kang et
al., 1992). The cytoplasmic PTKs, particularly Lck, whichOur simplified model depicts multiple pathways generated by acti-
vation of PTKs leading to stimulation of AP-1 and NF-AT activities. is required for both JNK and ERK activation, are very
A Ras-dependent pathway leads to ERK activation, while a Rac- likely targets for the mechanism responsible for T cell
dependent pathway leads to JNK activation. ERK and JNK are re- anergy. Definition of the signaling components leading
quired for maximal induction of AP-1 activity, which cooperates with
from PTKs to MAPKs provides important clues regard-NF-ATc to bind the NF-AT element and activate NF-AT-dependent
ing the mechanisms used by T cells to integrate andtranscription. Syk generates signals that result in activation of PKC
interpret the multiple signals that lead to activation orand calcineurin (CN), which converge on Rac, leading to JNK activa-
tion. Rac and Syk synergistically activate JNK, suggesting that Rac anergy.
may account for coupling another pathway parallel to the one origi-
nating from Syk (such as from CD28) to JNK activation. Alternatively Experimental Procedures
or at the same time, Syk may generate another signal (different from
the one[s] leading to PKC and calcineurin activation) that synergizes Antisera and Proteins
with Rac, leading to potent JNK activation. Activation of CN also Anti-HA and anti-M2 antibodies have been described previously
leads to dephosphorylation and translocation of NF-ATc to the nu- (Minden et al., 1995). Anti-JNK1 (333.8) and anti-Myc were obtained
cleus, where it binds cooperatively with AP-1 to NF-AT response from PharMingen and anti-phospho-ERK from New England Bio-
elements. In the case of AP-1 the signal is carried to the nucleus labs. Anti-ERK2, anti-c-Jun, and anti-phospho-c-Jun were obtained
by ERK and JNK, leading to c-fos and c-jun induction. from Santa Cruz Biotechnology. Anti-CD3 monoclonal antibody
OKT3 was provided by Steve Hedrick, and anti-CD28 monoclonal
antibody 9.3 was generously provided by Carl June and Bristol
Myers Squibb. Lckpolyclonal antiseraand Ras monoclonal antibodyAn alternative explanation is that Rac is more intimately
were provided by B. Sefton. Expression and purification of glutathi-
involved in the CD28 pathway, since CD28 by itself does one S-transferase (GST)±c-Jun(1±79) have been described (Hibi et
not induce NF-AT or AP-1 transcriptional activities but al., 1993). Myelin basic protein (MBP) was purchased from Sigma.
can potentiate their activation by PMA1Ca21 ionophore
(Su et al., 1994; data not shown). The effect of Rac, as Expression Vectors, Reporters, and Transfections
The PTK expression vectors were tagged with the HA epitope bywell as the effect of PMA and part of the effect of Syk
creating an NcoI site at the AUG codons of the different open readingon the NF-AT driven reporter, is most likely due to stimu-
frames by polymerase chain reaction mutagenesis. The mutatedlation of AP-1 activity, which facilitates DNA binding of
cDNAs were then subcloned into the SRa vector containing 33 HA
the Ca21- and calcineurin-responsive NF-ATc transcrip- epitope sequence (Minden et al., 1994). Lck expression vectors
tion factors (Rao, 1994). While the Ras-dependent signal (wild-type Lck, Lck(F505), and HSB2-A1(Lck)) were gifts from M.
Kamps and B. Sefton. Fyn expression construct (wild-type FynT)that contributes to stimulation of NF-AT activity isproba-
was provided by R. Perlmutter (Cooke and Perlmutter, 1989). Thebly mediated through ERK activation, leading to c-fos
Fyn(F528) mutant was created by site-directed mutagenesis usinginduction, the Ras-independent but Rac-dependent sig-
the primer 59-GCCACAGAGCCCCAGTTTCAGCCCGGTGAAAACCTnal is likely to be propagated via JNK (and p38), leading
GTG-39 (Chameleon site-directed mutagenesis kit, Stratagene).
to c-jun induction (Karin, 1995). In support of this inter- Syk and ZAP70 expression vectors were gifts from A. Altman and
pretation, which is illustrated in Figure 7, we find that A. Weiss, respectively. M2- and HA-tagged JNK and ERK constructs
and Rac1(V12) and Rac1(N17) vectors have been described (Mindeninduction of the NF-AT-LUC reporter is partially inhibited
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et al., 1995). All constructs were subcloned into the pSRa vector Foundation grant 823A-046706. This work was supported by NIH
grants CA50528 and ES04151.(Minden et al., 1995). 279 c-jun-Luc and 260 Col-LUC reporters
have been described (Deng and Karin, 1993; Su et al., 1994). NF-
AT-LUC was provided by G. Crabtree (Northrop et al., 1993 ). Received September 18, 1997; revised November 17, 1997.
Tag-Jurkat cells, stably expressing SV40 large T antigen (a gift
from G. Crabtree) were grownto about106 cells/ml and concentrated
Referencesto 2 3 107 cells/ml. Of this cell suspension, 500 ml was used for
each transfection point. Cells werepulsed using BioRad GenePulser
Arpaia, E., Shahar, M., Dadi, H., Cohen, A., and Roifman, C.M. (1994).at 250 V, 960 mF in a 0.4 cm cuvette. Cells were incubated on ice
Defective T cell receptor signaling and CD81 thymic selection infor 10 minand then resuspended in 10 ml of complete RPMI medium.
humans lacking ZAP-70 kinase. Cell 76, 947±958.For reporter gene assays, cells were stimulated 24 hr after transfec-
August, A., Gibson, S., Kawakami, Y., Kawakami, T., Mills, G.B.,tion and then harvested after another 12 hr of incubation. Cells were
and Dupont, B. (1994). CD28 is associated with and induces thelysed in 100 ml of buffer II (100 mM Tris-Ac [pH 7.8], 10 mM MgAc, 1
immediate tyrosine phosphorylation and activation of the Tec familymM EDTA) with 1% Triton X-100 and 1 mM dithiothreitol. Luciferase
kinase ITK/EMT in the human Jurkat leukemic T cell line. Proc. Natl.activity was determined using luminometer (MicroLumat, EG&G
Acad. Sci. USA 91, 9347±9351.Berthold). For kinase assays, cells were harvested 36 hr after trans-
fection. Bu, J.Y., Shaw, A.S., and Chan, A.C. (1995). Analysis of the interac-
tion of ZAP-70 and Syk protein-tyrosine kinases with the T-cell
antigen receptor by plasmon resonance. Proc. Natl. Acad. Sci. USA
Cell Culture and Stimulations 92, 5106±5110.
Jurkat wild-type and variant cells (JCaM1.6 and Tag) (gifts from A.
Cantrell, D.A. (1996). T cell antigen receptor signal transductionWeiss and G. Crabtree, respectively) were grown in RPMI with 10%
pathways. Cancer Surveys 27, 165±175.fetal calf serum, 1 mM glutamate, 100 U/ml penicillin, and 100 mg/
Cavigelli, M., Dolfi, F., Claret, FX., and Karin, M. (1995). Inductionml streptomycin (complete medium) at 378C with 5% CO2. When
of c-fos expression through JNK-mediated TCF/Elk-1 phosphoryla-indicated, cells were pretreated with 100 ng/ml CsA (Sandoz) or
tion. EMBO J. 14, 5957±5964.SB202190 (SmithKline Beecham) for 10±15 min. Cells were then
stimulated with 10 ng/ml PMA from Sigma, 0.5 mg/ml A23187 (Calbi- Chan, A.C., Iwashima, M., Turck, C.W., and Weiss, A. (1992). ZAP-
ochem), or 10 mg/ml anti-CD3, 2 mg/ml anti-CD28 (in solution) either 70: a 70 kd protein tyrosine kinase that associates with the TCR z
alone or in combination for 30 min before harvesting. Cells were chain. Cell 71, 649±662.
lysed in 200 ml of whole-cell extract (WCE) lysis buffer (Hibi et al., Chu, D.H., Spits, H., Peyron, J.F., Rowley, R.B., Bolen, J.B., and
1993). Weiss, A. (1996). The Syk protein tyrosine kinase can function inde-
pendently of CD45 or Lck in T cell antigen receptor signaling. EMBO
J. 5, 6251±6261.Immunoprecipitation and Immunoblotting
Cheng, A.M., Negishi, I., Anderson, S.J., Chan, A.C., Bolen, J., Loh,For immunoblotting, 30 mg of cell lysate were resolved by 10%
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PBS-T once for 15 min and twice for 5 min before being incubated Coso, O.A., Chiariello, M., Yu, J.-C., Teramoto, H., Crespo, P., Xu,
with secondary antibody conjugated to horseradish peroxidase. The N., Miki, T., and Gutkind, J.S. (1995). The small GTP-binding proteins
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tion of inactive heterodimers. Genes Dev. 7, 479±490.
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